Drug safety monitoring [10]

JAMA

Volumn 296, Issue 13, 2006, Pages 1590-

  Ruck, Bruce ^a   Marcus, Steven ^a   Kashani, John ^a   Vassilev, Zdravko ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL PRACTICE; DATA BASE; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; FOLLOW UP; HEALTH CARE PERSONNEL; HEALTH CENTER; HUMAN; LETTER; MEDICAL LITERATURE; PRIORITY JOURNAL; FACTUAL DATABASE; HEALTH SURVEY; NOTE; POISON CENTER; POSTMARKETING SURVEILLANCE; UNITED STATES;

DRUG;

DATABASES, FACTUAL; HUMANS; PHARMACEUTICAL PREPARATIONS; POISON CONTROL CENTERS; POPULATION SURVEILLANCE; PRODUCT SURVEILLANCE, POSTMARKETING; UNITED STATES;

EID: 33749331667     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: None     Document Type: Letter

References (5)

1. Strom BL. How the US drug safety system should be changed. JAMA. 2006;295:2072-2075.
2. Litovitz T. The TESS database: use in product safety assessment. Drug Saf. 1998;18:9-19.
3. Centers for Disease Control and Prevention. Toxic Exposure Surveillance System. MMWR Morb Mortal Wkly Rep. 2004;53(suppl):262.
4. Wolkin AF, Patel M, Watson W, et al. Early detection of illness associated with poisonings of public health significance. Ann Emerg Med. 2006;47:170-176.
5. Woolf A, Litovitz T. Reporting of adverse events. N Engl J Med. 2003;348:1410-1411.